These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 30988053)

  • 1. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms.
    Nozaki K; Nakano M; Iwakami C; Fukami T; Nakajima M
    Drug Metab Dispos; 2019 Jun; 47(6):639-647. PubMed ID: 30988053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
    Nakano M; Fukami T; Nakajima M
    J Pharmacol Exp Ther; 2019 Sep; 370(3):408-415. PubMed ID: 31270214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminases acting on RNA modulate the expression of the human pregnane X receptor.
    Takemoto S; Nakano M; Nozaki K; Fukami T; Nakajima M
    Drug Metab Pharmacokinet; 2021 Apr; 37():100367. PubMed ID: 33515843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
    Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
    J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of adenosine at the N
    Nakano M; Ondo K; Takemoto S; Fukami T; Nakajima M
    Biochem Pharmacol; 2020 Jan; 171():113697. PubMed ID: 31706844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s.
    Chaudhry AS; Thirumaran RK; Yasuda K; Yang X; Fan Y; Strom SC; Schuetz EG
    Drug Metab Dispos; 2013 Aug; 41(8):1538-47. PubMed ID: 23704699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine N
    Isono M; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2022 Nov; 205():115247. PubMed ID: 36113565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in ADAR1 expression by exposure to cigarette smoke enhances susceptibility to oxidative stress.
    Takizawa M; Nakano M; Fukami T; Nakajima M
    Toxicol Lett; 2020 Oct; 331():22-32. PubMed ID: 32439581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.
    Jayan GC; Casey JL
    J Virol; 2002 Apr; 76(8):3819-27. PubMed ID: 11907222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Evaluation of the Effects of RNA-Editing Proteins ADAR and ADARB1 on the Expression of the Drug-Metabolizing Enzymes in HepaRG Cells.
    Collins JM; Wang D
    Drug Metab Dispos; 2023 Nov; 51(11):1508-1514. PubMed ID: 37532539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of ADARs in planarians supports a bilaterian ancestral role in suppressing double-stranded RNA-response.
    Bar Yaacov D
    PLoS Pathog; 2022 Jan; 18(1):e1010250. PubMed ID: 35041722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA.
    Kamiyama Y; Matsubara T; Yoshinari K; Nagata K; Kamimura H; Yamazoe Y
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):287-98. PubMed ID: 17827783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha.
    Ferguson SS; Chen Y; LeCluyse EL; Negishi M; Goldstein JA
    Mol Pharmacol; 2005 Sep; 68(3):747-57. PubMed ID: 15933212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes.
    Kim KA; Chung J; Jung DH; Park JY
    Eur J Clin Pharmacol; 2004 Oct; 60(8):575-81. PubMed ID: 15365656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Editing, ADAR1, and the Innate Immune Response.
    Wang Q; Li X; Qi R; Billiar T
    Genes (Basel); 2017 Jan; 8(1):. PubMed ID: 28106799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.